GlassScriptPhysician profile
Emma J Patterson
NPI 1174515431
$64,573.86
in general payments reported to CMS, 2019-2025
17 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $1,453 · 2021: $798 · 2022: $2,770 · 2023: $2,787 · 2024: $8,837 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,548 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,292 · Food and Beverage: $3,913 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,417 · Travel and Lodging: $783 · Entertainment: $45.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,548.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,292.29 |
| Food and Beverage | $3,913.24 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,416.65 |
| Travel and Lodging | $782.57 |
| Entertainment | $45.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $36,847.81 | 2019 | |
| Medtronic, INC. | $12,632.07 | 2022-2025 | Signia, Venaseal, Sonicision |
| Endolumik, INC. | $8,758.94 | 2025 | Endolumik Gastric Calibration Tube |
| Ethicon US, LLC | $2,176.30 | 2019-2025 | Vistaseal, Echelon; Endopath, Surgiflo Hemostatic Matrix |
| Ethicon INC. | $1,515.00 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $797.13 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Covidien LP | $651.80 | 2019-2020 | |
| Reshape Lifesciences INC. | $276.21 | 2021-2023 | |
| Teleflex LLC | $255.54 | 2023 | Titan Sgs Standard Gastric Stapler |
| Phathom Pharmaceuticals, INC. | $181.13 | 2024 | Voquezna |
| Davol INC. | $161.68 | 2019-2022 | |
| Baxter Healthcare | $124.75 | 2019-2024 | Perclot |
| Intuitive Surgical, INC. | $76.76 | 2020 | |
| Novo Nordisk INC | $57.30 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Heron Therapeutics, INC. | $22.67 | 2023 | Aponvie |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $21.32 | 2023 | |
| Lilly USA, LLC | $17.45 | 2025 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emma Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.